Schizophrenia

MAPrc’s researchers are currently working on a number of projects developing new treatments and diagnostic methods for people experiencing schizophrenia

The following projects are currently recruiting participants.  Please contact us if you wish to receive futher information or to take part in a project. 

Tel: 61 3 9076 6581

Email: participate.maprc@monash.edu


 
Smoking Cessation/Harm reduction using Vaporised Nicotine
24 week smoking harm reduction study trialling e-cigarettes and inhalators for people with severe persistant mental illness including psychosis disorders. For more information click here or contact Gayan De Mel on
tel: (03) 9067 8045 or email gayan.demel@monash.edu
 
tDCS for cognition in schizophrenia
Investigating the neurobiological and neurocognitive effects of multiple sessions of transcranscranial Direct Current Stimulation for working memory enhancement in people with schizophrenia. For further information please contact Ms Kirsten Gainsford on tel: (03) 9076 6592 or Email: kirsten.gainsford@monash.edu
 
 
Adjunctive SERM Hormone Treatment for Men and Women with Schizophrenia and Schizoaffective Disorder
Men and women who are 18 and over, with schizophrenia or schizoaffective disorder, are invited to take part in a 12-week adjunctive treatment study that is underway in Melbourne. Hormones are known to play a role in the expression of schizophrenia and related disorders. The Monash Alfred Psychiatry research centre is investigating whether a medication that targets hormone receptors in the brain, when taken in combination with regular antipsychotic medication, can better improve psychotic symptoms, mood and cognitive functioning. Participants will be reimbursed for their time and travel can be negotiated. For further details click here or contact Natalie Thomas on (03) 9076 5033 or via email natalie.thomas@monash.edu
 
NRAMP - National Register for Antipsychotics in Pregnancy
Observational study of women who are taking or have taken antipsychotic medications during their pregnancy. For further information click here or contact Heather Gilbert on 9076 6591 or email heather.gilbert@monash.edu 
 
EVestG (ElectrovestibuloGraphy)
We are currently trialling a new technique, EVestG (ElectrovestibuloGraphy) which is being investigated as a possible objective method for diagnosing participants with Schizophrenia.  For further information click here or contact MAPrc on 9076 6564 or email maprc@monash.edu 
 
Genes and brain function
A large collaborative investigation examining how genes and brain function influence the production of language symptoms, including auditory hallucinations and confused speech.  For futher information click here or contact Dr Wei Lin Toh on 9076 6564 or email wei.lin.toh@monash.edu
 
Computer-based cognitive training for people with schizophrenia or schizoaffective disorder
We are interested in the unique benefits of cognitive training for people with schizophrenia or schizoaffective disorder when compared to regular computer games. Computer sessions are offered in groups. Participants may be allocated to either the training group or the computer game group. Please contact Shayden Bryce on 0424515907 or shayden.bryce@monash.edu for more information.
 
SAVVy: Smartphone-Assisted coping focused interVention for Voices
We are investigating the effects of a short psychological therapy which aims to help people cope with distressing voice hearing experiences. This therapy involves four face-to-face sessions with a therapist along-side the use of a smartphone app between sessions. Participants will be allocated to receive the therapy or a control group who will not receive the therapy. For more information, please visit the trial website (www.savvyresearchtrial.com) or contact Imogen Bell on (03) 9076 6564 or savvyresearchtrial@gmail.com.
 

 MAPrc Monash Alfred Psychiatry Research Centre, Level 4, 607 St Kilda Road, Melbourne 3004

 © MAPrc 2013. Designed and hosted by Infoxchange Australia